Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis: A study of 9396 French people

British Journal of Haematology

Volumn 118, Issue 4, 2002, Pages 1170-1178

  Deugnier, Yves ^a,b   Jouanolle, Anne Marie ^b   Chaperon, Jacques ^c   Moirand, Romain ^a   Pithois, Catherine ^d   Meyer, Jean François ^d   Pouchard, Michel ^e   Lafraise, Bernard ^f   Brigand, Alain ^d   Caserio Schoenemann, Céline ^c   Mosser, Jean ^b   Adams, Paul ^g   Le Gall, Jean Yves ^b   David, Véronique ^b  

^a Service des Maladies du Foie   (France)

^b PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^c Ecole Nationale de la Sante Publique   (France)

^d Centres d'Examens de Santé des Caisses Primaires d'Assurance Maladie des Côtes d'Armor   (France)

^e d'Ille et Vilaine   (France)

^f De Loire Atlantique   (France)

^g UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

C282Y homozygosity; Genetic haemochromatosis; Penetrance; Screening

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; ANAMNESIS; ARTHRALGIA; ARTICLE; BIOCHEMISTRY; BLOOD ANALYSIS; CHEMICAL ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISCRIMINANT ANALYSIS; FAMILY; FEMALE; FERRITIN BLOOD LEVEL; GENE EXPRESSION; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON DEFICIENCY; IRON METABOLISM; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PHENOTYPE; PREMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; VALIDATION PROCESS;

ADULT; AGE FACTORS; BIOLOGICAL MARKERS; FEMALE; FERRITINS; GENOTYPE; HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; MALE; MASS SCREENING; MEMBRANE PROTEINS; MIDDLE AGED; MODELS, STATISTICAL; MUTATION; PENETRANCE; PREVALENCE; SEX; TRANSFERRIN;

EID: 18544376989     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03718.x     Document Type: Article

References (32)

1. Population screening for hemochromatosis
2. Nonexpressing homozygotes for C282Y hemochromatosis: Minority or majority of cases?
3. The effect of arthritis on the quality of life in hereditary hemochromatosis
4. Genotypic/phenotypic correlations in genetic hemochromatosis: Evolution of diagnostic criteria
5. Long-term survival analysis in hereditary hemochromatosis
6. The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis
7. Population screening for hemochromatosis: A comparison of unbound iron-binding capacity, transferrin saturation, and C282Y genotyping in 5,211 voluntary blood donors
8. Disorders of iron metabolism
9. Screening for hemochromatosis: High prevalence and low morbidity in an unselected population of 65,238 persons
10. Hemochromatosis population screening
11. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic
12. A genotypic study of 217 unrelated probands diagnosed as 'genetic haemochromatosis' on classical phenotypic criteria
13. Disease-related conditions in relatives of patients with hemochromatosis
14. The significance of haemochromatosis gene mutations in the general population: Implications for screening
15. High prevalence of the hemochromatosis-associated Cys282Tyr HFE gene mutation in a healthy Norwegian population in the city of Oslo, and its phenotypic expression
16. Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis
17. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
18. HFE mutations, iron deficiency and overload in 10,500 blood donors
19. Haemochromatosis and HLA-H
20. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis
21. Haemochromatosis and HLA-H
22. Prevalence of the C282Y mutation in Brittany: Penetrance of genetic hemochromatosis?
23. Global prevalence of putative haemochromatosis mutations
24. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population
25. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results
26. Clinical features of genetic hemochromatosis in women compared with men
27. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis
28. A population-based study of the clinical expression of the hemochromatosis gene
29. Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing
30. A simple genetic test identifies 90% of UK patients with haemochromatosis
31. Haemochromatosis gene C282Y homozygotes in an elderly male population
32. Inborn errors of metabolism: Iron